<DOC>
	<DOC>NCT00729599</DOC>
	<brief_summary>To prove the safety, in normal conditions, of the Cepacol Teen, a formulation to odontological usage.</brief_summary>
	<brief_title>Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.</brief_title>
	<detailed_description />
	<mesh_term>Dermatologic Agents</mesh_term>
	<mesh_term>Cetylpyridinium</mesh_term>
	<criteria>Integral buccal mucous (without oral pathologies); Normal odontological exams; Lactation or gestational risk or gestation; Use of Antiinflammatory or immunosuppression drugs 15 days before the study; Being in odontological treatment; Pathological or mucous disease which can interfere or active gynaecological disease which may interfere wtih study results; Personal history of allergic disease in the area to be treated; Allergic or atopic history;</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>